Skip to main content
Veterinary Medicines

Cefabactin 250 mg Tablets for Dogs and Cats

Authorised
  • Cefalexin monohydrate

Product identification

Medicine name:
Cefabactin 250 mg tablets for dogs and cats
Cefabactin 250 mg Tablets for Dogs and Cats
Active substance:
  • Cefalexin monohydrate
Target species:
  • Cat
  • Dog
Route of administration:
  • Oral use
  • Oral use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    262.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Cat
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • Cardboard box of 9 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 6 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 4 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 3 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 25 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 2 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 8 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 7 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 5 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 10 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box of 1 blister (Aluminium - PVC/PE/PVDC) of 10 tablets
  • Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 41821/4034
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0201/002
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."